Nemluvio (nemolizumab-ilto) is a prescription drug approved to treat certain skin conditions. Nemluvio comes in prefilled pens for giving as injections under the skin. Specifically, Nemluvio is used ...

Patients may self-inject Nemluvio after receiving training on SC injection technique. The Food and Drug Administration (FDA) has approved Nemluvio ® (nemolizumab-ilto) for the treatment of adults with ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved Nemluvio (nemolizumab-ilto) to treat adults with prurigo nodularis. The approval was supported ...

Nemluvio (nemolizumab-ilto) is used to treat certain inflammatory skin conditions. Side effects of this drug can vary depending on the condition being treated. More common side effects include ...

Nemluvio is given as a subcutaneous injection to help treat eczema and prurigo nodularis. Dosage for Nemluvio may depend on the condition being treated. But, the starting dose for both conditions is ...

Approval of Nemluvio was based on positive results from the Phase III OLYMIA trials, which demonstrated significant itch reductions. The FDA has approved Galderma’s Nemluvio (nemolizumab), a ...